Results 111 to 120 of about 18,746 (183)

Dynamic associations of cholinesterase inhibitors and memantine with cognitive trajectories in individuals with Alzheimer's or mixed dementia: a real-world analysis using the quality registry SveDem. [PDF]

Alzheimers Res Ther
Chen C, Mo M, Åkerman M, Garcia-Ptacek S, Xu H, Eriksdotter M.   +5 more
europepmc   +1 more source

Design and synthesis of new phosphazine and triazole derivatives for treatment of Alzheimer's disease: modulating ROS/JNK and Wnt/β-catenin signaling pathways. [PDF]

RSC Adv
Salah RS, El-Sayed NF, El-Hussieny M, Mansour ST, Othman M, Fouad MA, Rashdan HRM, Ewies EF, Gharib HSA, Elsayed GH.   +9 more
europepmc   +1 more source

Pharmacokinetics of Double-Layer Patches With Microneedles Containing Procyclidine and Rivastigmine in Guinea Pigs. [PDF]

Basic Clin Pharmacol Toxicol
Moon M, Won J, Lee YW, Jeon S, Yoon Y, Jeong JH, Kang W.   +6 more
europepmc   +1 more source

Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment. [PDF]

J Alzheimers Dis
Heo RJ, Negida A, Barrett MJ, Chrenka EA, Bayram E, Kane JPM, Werner AM, Rossom RC, Wyman-Chick KA.   +8 more
europepmc   +1 more source

Antiglycative Properties of Anti-Dementia Drugs-In Vitro, In Silico Studies and a Systematic Literature Review. [PDF]

Antioxidants (Basel)
Orlof W, Ladny JR, Michalak D, Zendzian-Piotrowska M, Zalewska A, Maciejczyk M.   +5 more
europepmc   +1 more source

The role of genetic polymorphisms on drug response in Alzheimer's disease: a systematic review. [PDF]

BMC Med Genomics
Climacosa FMM, Ornos EDB, Gapaz NCLL, Guantia MGR, Cruz JMC, Manalo RVM, Yu ML, Qureshi AP, Carampel AC, Asis JLB, Reyes JCB, Dacasin AB, Anlacan VMM.   +12 more
europepmc   +1 more source

PNP15 EVALUATION OF THE RELATIONSHIP BETWEEN EPILEPSY SEVERITY AND UTILITY [PDF]

, 1938
Selai, C, Kaiser, S, Trimble, M, Price, M   +3 more
core   +1 more source

Network meta-analysis of the efficacy of pharmacological treatments for post-stroke cognitive impairment and vascular cognitive impairment. [PDF]

Front Neurol
Li W, Liu X, Gao C, Li W, Liao X.
europepmc   +1 more source

Treatment patterns of symptomatic treatments for Alzheimer's disease and related dementias. [PDF]

BMC Geriatr
Deng H, Lee TA, Gaber CE, Kim K, Crawford SY, Bayliss EA, Singh S, Young JG, Toh S, Li X.   +9 more
europepmc   +1 more source

Bridging the gap: Efficacy of combined therapies for cognitive, behavioral, and functional outcomes in Alzheimer's disease - results from a systematic review and network meta-analysis. [PDF]

J Alzheimers Dis
Boongird C, Anothaisintawee T, Tearneukit W, Wongpipathpong W, Suthutvoravut U, Thongpan M, Pongsettakul N, Attia J, McKay GJ, Rattanasiri S, Thakkinstian A.   +10 more
europepmc   +1 more source